Willingness to Pay for Cancer Genetic Testing in a Tertiary Healthcare Centre

Authors

  • Aizuddin AN Department of Community Health, Faculty of Medicine, National University of Malaysia, Jalan Yaacob Latif, Kuala Lumpur, Malaysia
  • Syed Rusli SAS Department of Community Health, Faculty of Medicine, National University of Malaysia, Jalan Yaacob Latif, Kuala Lumpur, Malaysia
  • Ramdzan AR Department of Community Health, Faculty of Medicine, National University of Malaysia, Jalan Yaacob Latif, Kuala Lumpur, Malaysia
  • Syed Omar SA Faculty of Education, National University of Malaysia, Selangor, Malaysia.
  • Mahmud Z Faculty of Education, National University of Malaysia, Selangor, Malaysia
  • Abdul Latiff Z Department of Paediatrics, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia
  • Shah SA Department of Community Health, Faculty of Medicine, National University of Malaysia, Jalan Yaacob Latif, Kuala Lumpur, Malaysia
  • Amat S Faculty of Education, National University of Malaysia, Selangor, Malaysia.
  • Ismail F Department of Oncology & Radiotherapy, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia
  • Keng WT Genetic Department, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • Ch’ng GS Genetic Department, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • Rais H Department of Education Psychology & Counseling, Kulliyyah of Education, International Islamic University Malaysia, Kuala Lumpur, Malaysia
  • Aljunid SM Department of Health Policy and Management, Faculty of Public Health, Health Science Center, Kuwait University, Kuwait

DOI:

https://doi.org/10.31436/imjm.v20i3.1953

Keywords:

Willingness to pay, Genetic testing, Cancer, Genetic

Abstract

INTRODUCTION: Increasing use of predictive genetic testing to address hereditary cancer risk has been commonly assessed by cost sharing practices. Little is known about how demographics, knowledge, attitude and practices may influence these individuals’ willingness to pay for cancer genetic testing. The objective of this research was to determine factors associated with willingness to pay for cancer genetic testing. MATERIALS AND METHODS: A self-administered questionnaire was distributed to 175 respondents in the oncology and day care unit in one of tertiary healthcare centre. The respondents comprised cancer patients, their family members and the community. RESULTS: A total of 117 (66.9%) participants were willing to pay for cancer genetic testing. Ninety three (79.5%) of respondents were willing to pay from their own pocket with a mean of MYR1201.77 (SD976.72) and 95 (54.3%) respondents were willing to pay, shared with insurance. There were significant associations between willingness to pay with status of respondent as patients or family members or community, gender, race, educational level, income, knowledge and attitude. CONCLUSION: This is the first study to evaluate factors associated with willingness to pay not only among cancer patients but also their family members and the community. These findings reveal that majority of respondents believe there is valuable personal benefit based on genetic risk information and they are willing to pay for it.

Downloads

Download data is not yet available.

Downloads

Published

01.07.2021

How to Cite

AN, A. ., SAS, S. R. ., AR, R. ., SA, S. O. ., Z, M., Z, . A. L. ., SA, S. ., S, A. ., F, I. ., WT, K., GS, C. ., H, R. ., & SM, A. . (2021). Willingness to Pay for Cancer Genetic Testing in a Tertiary Healthcare Centre . IIUM Medical Journal Malaysia, 20(3). https://doi.org/10.31436/imjm.v20i3.1953